Big Pharma Split Corp (PRM.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Non-Interest Income | 435 | 312 | 3,711 | 5,359 | 589 |
| Sales | 435 | 312 | 3,711 | 5,359 | 589 |
| Pre-tax Income | 13 | -140 | 3,146 | 4,854 | 265 |
| Other Income | 13 | -140 | 3,146 | 4,854 | 265 |
| Net Income | $13 | $-140 | $3,146 | $4,854 | $265 |
| EPS Basic Continuous Ops | -0.47 | -0.53 | 1.58 | 3.27 | -0.22 |
| EPS Basic Total Ops | -0.47 | -0.53 | 1.58 | 3.27 | -0.22 |
| EPS Diluted Continuous Ops | -0.47 | -0.53 | 1.58 | 3.27 | -0.22 |
| EPS Diluted Total Ops | -0.47 | -0.53 | 1.58 | 3.27 | -0.22 |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $N/A |